Review
Copyright ©The Author(s) 2016.
World J Nephrol. Jul 6, 2016; 5(4): 308-320
Published online Jul 6, 2016. doi: 10.5527/wjn.v5.i4.308
Table 3 Possible treatment of C3 glomerulopathies
Nonspecific treatment
Replace deficient gene products
Plasma infusion
Liver Transplantation
Eliminate autoantibodies and/or mutant proteins
Plasma exchange
Immunosuppression
Treatment of plasma cell dyscrasia
Inhibition of complement activation
Eculizumab (anti C5)
Inhibition of the C3 Convertase
Renal transplantation
New trials ongoing